Meta-regression of 15 RCTs (6,814 patients) in multiple sclerosis: treatment effects on serum/plasma NfL were moderately associated with effects on new/enlarging T2 lesions (R2 0.42), relapse rate (R2 0.33) and disability worsening (R2 0.30), but not brain volume change.
Meta-analysisn = 6,814
Pretzsch et al. Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trials